Latest irbesartan Stories

2011-01-14 12:50:05

Bristol-Myers Squibb Co said Thursday that it is recalling 64 million tablets of the blood pressure medicine Avalide in the U.S. and Puerto Rico due to the potential for reduced effectiveness. The move marked the second major recall in less than four months of the medicine co-marketed with French drugmaker Sanofi-Aventis. Bristol-Myers recalled 62 lots, or 60 million tablets, of the drug manufactured in Puerto Rico.  The company said that the new recall involved 65 lots of Avalide...

2009-09-01 10:38:50

Most research in atrial fibrillation (AF) has focused on reducing stroke and other embolic events. Yet heart failure occurs more frequently in AF patients, but has not been the focus of intervention research.In a major international trial, researchers from McMaster University in Canada, found that the hypertension drug irbesartan reduced the risk of heart failure complications and the combination of stroke, other embolic events and transient ischemic events, also known as ministrokes, in...

2008-12-04 10:40:00

A medication used for high blood pressure does not improve a common form of heart failure, according to new results from a large, international study.The study, which included researchers at Wake Forest University Baptist Medical Center in key leadership positions, appears in this week's issue of the New England Journal of Medicine, published today.The findings are disappointing to researchers, who continue to study other medications in search of a successful treatment for the condition,...

2008-06-17 09:01:12

Mylan has announced that its subsidiary, Mylan Pharmaceuticals, has received tentative approval from the FDA for its abbreviated new drug application for Irbesartan and hydrochlorothiazide tablets, 150mg/12.5mg and 300mg/12.5mg. Irbesartan and hydrochlorothiazide tablets, indicated for the treatment of hypertension, are the generic version of Sanofi Aventis's Avalide tablets. Currently, Mylan has 92 abbreviated new drug applications pending FDA approval, 20 of which are potential...

2008-06-16 15:00:49

PITTSBURGH, June 16 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Irbesartan and Hydrochlorothiazide Tablets, 150 mg/12.5 mg and 300 mg/12.5 mg. Irbesartan and Hydrochlorothiazide Tablets, indicated for the treatment of hypertension, are the generic version of Sanofi Aventis' Avalide(R) Tablets, which...

Word of the Day
  • Color; hue; complexion.
This word is Middle English in origin.